International Society For Cns Clinical Trials And Methodology In
International Society For CNS Clinical Trials And Methodology In consistently generates surpluses and grows assets with no reported executive compensation.
EIN: 201872069 · Nashville, TN · NTEE: B60 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $927K |
| Total Expenses | $592K |
| Program Spending | 85% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $5.8M |
| Transparency Score | 90/100 |
Is International Society For Cns Clinical Trials And Methodology In Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
International Society For Cns Clinical Trials And Methodology In directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About International Society For Cns Clinical Trials And Methodology In
International Society For Cns Clinical Trials And Methodology In (EIN: 201872069) is a nonprofit organization based in Nashville, TN, classified under NTEE code B60. The organization reported total revenue of $927K and total assets of $6.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of International Society For Cns Clinical Trials And Methodology In's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
International Society For Cns Clinical Trials And Methodology In is a small nonprofit that has been operating for 20 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 3.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $856K |
| Total Expenses | $592K |
| Surplus / Deficit | +$264K |
| Total Assets | $6.2M |
| Total Liabilities | $407K |
| Net Assets | $5.8M |
| Operating Margin | 30.9% |
| Debt-to-Asset Ratio | 6.6% |
| Months of Reserves | 125.8 months |
Financial Health Grade: A
In 2023, International Society For Cns Clinical Trials And Methodology In reported a surplus of $264K with revenue exceeding expenses, holds 125.8 months of operating reserves (strong position), has a debt-to-asset ratio of 6.6% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), International Society For Cns Clinical Trials And Methodology In's revenue has grown at a compound annual growth rate (CAGR) of 3.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -15.1% | +3.7% | +23.9% |
| 2022 | +28.3% | +41.2% | -8.5% |
| 2021 | -0.2% | -22.0% | +16.3% |
| 2020 | -12.3% | -8.5% | +16.4% |
| 2019 | -22.2% | +2.2% | +13.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2006 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates International Society For Cns Clinical Trials And Methodology In with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, International Society For Cns Clinical Trials And Methodology In allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $264K, with revenue exceeding expenses.
- Debt-to-asset ratio: 6.6%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that no officers receive salaries from the organization. This is highly unusual for an organization with annual revenues approaching $1 million and suggests a volunteer-led or externally funded leadership structure, significantly reducing administrative overhead.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of International Society For Cns Clinical Trials And Methodology In's IRS 990 filings:
- Lack of detailed expense breakdown (program vs. admin vs. fundraising) in provided summary data
Strengths
The following positive indicators were identified for International Society For Cns Clinical Trials And Methodology In:
- Consistent revenue exceeding expenses, leading to healthy surpluses (e.g., $856,229 revenue vs. $592,049 expenses in 2023).
- Significant and consistent asset growth over time (from $2.19M in 2014 to $6.20M in 2023).
- Zero reported officer compensation across all filings, indicating high efficiency and transparency.
- Stable liabilities relative to growing assets, suggesting sound financial management.
Frequently Asked Questions about International Society For Cns Clinical Trials And Methodology In
Is International Society For Cns Clinical Trials And Methodology In a legitimate charity?
International Society For Cns Clinical Trials And Methodology In (EIN: 201872069) is a registered tax-exempt nonprofit based in Tennessee. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $927K. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does International Society For Cns Clinical Trials And Methodology In spend its money?
International Society For Cns Clinical Trials And Methodology In directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to International Society For Cns Clinical Trials And Methodology In tax-deductible?
International Society For Cns Clinical Trials And Methodology In is registered as a tax-exempt nonprofit (EIN: 201872069). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the International Society For Cns Clinical Trials And Methodology In CEO make?
International Society For Cns Clinical Trials And Methodology In's highest-compensated officer earns $1 annually. The organization reported $927K in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of International Society For Cns Clinical Trials And Methodology In's spending goes to programs?
International Society For Cns Clinical Trials And Methodology In directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does International Society For Cns Clinical Trials And Methodology In compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), International Society For Cns Clinical Trials And Methodology In is above average for NTEE category B60 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is International Society For Cns Clinical Trials And Methodology In located?
International Society For Cns Clinical Trials And Methodology In is headquartered in Nashville, Tennessee and files with the IRS under EIN 201872069. It is classified under NTEE code B60.
How many years of IRS 990 filings does International Society For Cns Clinical Trials And Methodology In have?
International Society For Cns Clinical Trials And Methodology In has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $927K in total revenue.
Is International Society For CNS Clinical Trials And Methodology In a good charity?
Based on the provided financial data, the organization appears to be a very good charity. It consistently generates surpluses, grows its assets, and reports no officer compensation, indicating strong financial health and efficient use of funds.
How has the organization's financial health changed over time?
The organization's financial health has consistently improved. Assets have grown from $2.19 million in 2014 to $6.20 million in 2023, and revenues have generally exceeded expenses, leading to healthy surpluses year over year.
What is the organization's approach to executive compensation?
The organization reports 0% officer compensation in all available filings, suggesting a volunteer-based executive leadership or that executive salaries are covered by an external entity. This is a strong indicator of low administrative costs.
Filing History
IRS 990 filing history for International Society For Cns Clinical Trials And Methodology In showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), International Society For Cns Clinical Trials And Methodology In's revenue has grown by 47.1%, moving from $582K to $856K. Total assets increased by 541.2% over the same period, from $968K to $6.2M. Total functional expenses rose by 42%, from $417K to $592K. In its most recent filing year (2023), International Society For Cns Clinical Trials And Methodology In reported a surplus of $264K, with revenue exceeding expenses. The organization holds $407K in liabilities against $6.2M in assets (debt-to-asset ratio: 6.6%), resulting in net assets of $5.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $856K | $592K | $6.2M | $407K | — | View 990 |
| 2022 | $1.0M | $571K | $5.0M | $152K | — | View 990 |
| 2021 | $786K | $404K | $5.5M | $327K | — | View 990 |
| 2020 | $788K | $519K | $4.7M | $294K | — | View 990 |
| 2019 | $898K | $567K | $4.0M | $349K | — | View 990 |
| 2018 | $1.2M | $555K | $3.5M | $259K | — | View 990 |
| 2017 | $828K | $553K | $3.0M | $160K | — | View 990 |
| 2016 | $718K | $550K | $2.7M | $231K | — | View 990 |
| 2015 | $887K | $551K | $2.3M | $165K | — | View 990 |
| 2014 | $903K | $545K | $2.2M | $309K | — | View 990 |
| 2013 | $740K | $482K | $1.7M | $133K | — | View 990 |
| 2012 | $657K | $471K | $1.3M | $104K | — | View 990 |
| 2011 | $582K | $417K | $968K | $35 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $856K, expenses of $592K, and assets of $6.2M (revenue -15.1% year-over-year).
- 2022: Revenue of $1.0M, expenses of $571K, and assets of $5.0M (revenue +28.3% year-over-year).
- 2021: Revenue of $786K, expenses of $404K, and assets of $5.5M (revenue -0.2% year-over-year).
- 2020: Revenue of $788K, expenses of $519K, and assets of $4.7M (revenue -12.3% year-over-year).
- 2019: Revenue of $898K, expenses of $567K, and assets of $4.0M (revenue -22.2% year-over-year).
- 2018: Revenue of $1.2M, expenses of $555K, and assets of $3.5M (revenue +39.5% year-over-year).
- 2017: Revenue of $828K, expenses of $553K, and assets of $3.0M (revenue +15.4% year-over-year).
- 2016: Revenue of $718K, expenses of $550K, and assets of $2.7M (revenue -19.1% year-over-year).
- 2015: Revenue of $887K, expenses of $551K, and assets of $2.3M (revenue -1.8% year-over-year).
- 2014: Revenue of $903K, expenses of $545K, and assets of $2.2M (revenue +22.0% year-over-year).
- 2013: Revenue of $740K, expenses of $482K, and assets of $1.7M (revenue +12.7% year-over-year).
- 2012: Revenue of $657K, expenses of $471K, and assets of $1.3M (revenue +12.8% year-over-year).
- 2011: Revenue of $582K, expenses of $417K, and assets of $968K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for International Society For Cns Clinical Trials And Methodology In:
Data Sources and Methodology
This transparency report for International Society For Cns Clinical Trials And Methodology In is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.